Original document(12 pages) Authorized document(12 pages) 中文版
    The present invention provides a preparation method of granules containing ibuprofen arginine composite, and the described composite is formed from ibuprofen arginine, diluting agent and adhesive, and said preparation method includes two steps of granurating and coating, and uses the coating material containing silicon dioxide to make coating liquor, and uses the prepared coating liquor to coat the granules. Said granules can be tabletted, also cna be capsulized, and the conventional solid soage form prepared by using said method has good stability, quick disintegration speed and high biological utilization rate.
Application Number
申请号
200310108031 Application Date
申请日
2003.10.15
Title 名称 Method for preparing composition granules containing ibuprofen amino guanidyl valeric acid
Publication Number
公开号
1528278 Publication Date
公开日
2004.09.15
Approval Pub. Date Granted Pub. Date 2006.01.25
International Classification 分类号 A61K31/198,A61K9/16,A61P29/00
Applicant(s) Name
申请人
Rongli Medicine Sci. & Tech. Co., Ltd., Hangzhou
Address 地址 310012
Inventor(s) Name 发明人
Attorney & Agent 代理人 huang meijuan wang bing

  
Brufen arginine pseudoephedrine hydrochloride compound formulation
Compound prepn. contg. Brufen arginine codeine
Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method
Method for synthesizing medication Entecavir of anti hepatitis B
Organic bio-iodine and its use
Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof
Rhododeudron molle toxin drop pill and preparing method thereof
Use of tauring for preparine medicine enhancing leucocyte function
Non-injection pharmaceutical product containing novel houttuynine sodium bisulfite
Herba seu flos rorippae extract drop pill and preparing method thereof
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.